Science & Research
Vitamin D Supplement Found to Boost Chemotherapy Efficacy in Breast Cancer Patients
A Brazilian clinical trial reveals that daily vitamin D supplementation improves outcomes for women undergoing standard chemotherapy for breast cancer, highlighting a low-cost intervention with global implications.
New Book Aims to Close Awareness Gap on Women's Heart Disease Symptoms
Cardiologist Arash Bereliani releases 'What About Her Heart' to educate the public on how heart disease presents differently in women, addressing a critical gap in recognition and timely diagnosis.
NanoViricides Gains FDA Orphan Drug Designation for Measles Drug NV-387 Amid Global Outbreaks
NanoViricides received FDA Orphan Drug Designation for its broad-spectrum antiviral NV-387 to treat measles, offering incentives and supporting regulatory advancement as global cases rise.
New Study Links Breast Tissue Aging to Increased Breast Cancer Risk in Older Women
Research mapping breast tissue changes with age explains higher breast cancer rates in older women and may guide new treatments.
Powermax Minerals Refines Exploration Strategy at Atikokan, Identifies High-Priority Rare Earth Zones
Powermax Minerals has integrated geochemical and geophysical data to pinpoint priority target zones for rare earth elements at its Atikokan property in Ontario, advancing from early-stage sampling to targeted exploration.
Cardio Diagnostics Leverages AI and Biomarkers to Combat Cardiovascular Disease
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is advancing early detection of heart disease using a platform that combines artificial intelligence with multi-omic biomarker analysis, addressing the urgent need for innovation in cardiovascular care.
Telomir Pharmaceuticals Gains FDA Clearance for Telomir-Zn Phase 1/2 Trial in Triple-Negative Breast Cancer
Telomir Pharmaceuticals announced FDA IND clearance for Telomir-Zn to treat advanced triple-negative breast cancer, allowing a Phase 1/2 trial to proceed and marking a key step toward clinical development.
Stopping the ‘Silent Killer’: How to Check, Prevent and Manage High Blood Pressure
American Heart Association highlights that nearly half of U.S. adults have high blood pressure, many undiagnosed, and emphasizes lifestyle changes and monitoring to prevent heart disease and stroke.
Tonix Pharmaceuticals Advances Lyme Disease Prevention with Phase 1 Data and Plans for Phase 2 Study
Tonix Pharmaceuticals reported Phase 1 data for its Lyme disease prevention candidate TNX-4800 and announced plans for an adaptive Phase 2 field study, highlighting the unmet need for prophylactic options in the U.S.
Three Breakthroughs Indicate Quantum Computing May Arrive Sooner Than Expected
Recent advancements in hardware stability, real-world problem-solving, and error correction resource requirements suggest quantum computing could become practical earlier than projected.
Lexaria Bioscience Extends Material Transfer Agreement with PharmaCO Through 2026
Lexaria Bioscience has extended its Material Transfer Agreement with an undisclosed pharmaceutical company to evaluate its DehydraTECH technology for GLP-1 drugs, allowing for continued collaboration and review of upcoming R&D results.
Fitzroy Minerals Identifies Large Conductive Anomalies at Caballos Copper Project, Chile
Fitzroy Minerals reports that a MobileMT survey at its Caballos copper project in Chile has linked multiple large conductive anomalies to copper-molybdenum-gold drill intercepts, suggesting a porphyry-related hydrothermal system and potential for a district-scale mineralizing system.
Oncotelic's PDAOAI Platform Targets AI Bias in Pharma with Evidence-Interrogation Approach
Oncotelic Therapeutics' PDAOAI platform indexes over 125,000 PubMed abstracts on TGF-β signaling to generate testable hypotheses, addressing transparency and bias challenges in AI-driven drug discovery.
Study Finds Exercise and Ibuprofen May Alleviate Chemo Brain in Cancer Patients
New research suggests that exercise and the common over-the-counter drug ibuprofen can help combat cognitive decline in cancer patients undergoing chemotherapy and radiation, a condition known as chemo brain.
ARMR Sciences Advances Fentanyl Vaccine Toward Human Trials with Private Placement
ARMR Sciences Inc. completed a private placement financing led by Joseph Gunnar & Co. to advance its preventive fentanyl vaccine toward human trials, aiming to address the synthetic drug crisis.
Nicola Mining Begins 2026 Diamond Drilling at New Craigmont Copper Project, Targeting High-Grade Porphyry-Skarn Potential
Nicola Mining has launched its 2026 diamond drilling program at the New Craigmont Copper Project in British Columbia, targeting the Jotun anomaly to explore for a porphyry-skarn system, with implications for expanding copper resources near Canada's largest copper mine.
Helus Pharma Partners with TARA Mind to Boost Veteran Recruitment in Phase 3 Depression Trial
Helus Pharma collaborates with TARA Mind and VETS to recruit veterans for its Phase 3 trial of HLP003 for major depressive disorder, aligning with a recent executive order on mental health.
Brain Health Shaped by Lifetime Mental, Physical, Environmental and Lifestyle Factors, New AHA Statement Says
A new American Heart Association scientific statement highlights that brain health is influenced by a range of factors across the entire lifespan, including mental health, sleep, environment, and social conditions, offering opportunities for early intervention to reduce the risk of stroke, cognitive decline, and dementia.
New Molecule Shows Promise for Glioblastoma Treatment, Clinical Trial Underway
Researchers at Brown University Health have identified a molecule that may alter glioblastoma treatment, with a clinical trial planning direct surgical delivery to the tumor.
LIXTE Biotechnology Advances Precision Oncology with Novel PP2A Inhibitor LB-100
LIXTE Biotechnology Holdings is developing LB-100, a first-in-class PP2A inhibitor that enhances chemotherapy and immunotherapy while reducing side effects, with ongoing clinical trials for ovarian and colon cancers.
ESGold Corp. Launches District-Scale Survey to Unlock Full Potential of Montauban Gold-Silver Project
ESGold Corp. has expanded its ANT survey to 70 square kilometers at its Montauban project in Québec, aiming to define the full scale of a deep mineralized corridor and advance toward production.
8 Tips to Protect Your Vision as You Age, According to the National Eye Institute
The National Eye Institute offers eight actionable tips for maintaining eye health, emphasizing the importance of regular exams, healthy lifestyle choices, and managing chronic conditions to prevent vision loss.
TransCode Therapeutics Appoints Scientific Advisory Board Chair, Partners with Michigan State University to Advance RNA-Based Cancer Therapies
TransCode Therapeutics announced the appointment of Dr. Anna Moore as Chair of its Scientific Advisory Board and a sponsored research agreement with Michigan State University to advance its RNA-based therapeutic pipeline, including lead candidate TTX-MC138.
GeoVax Positions Gedeptin as Immune-Sensitizing Platform Amid Industry Shift to In Vivo Cancer Therapies
GeoVax highlights its gene-directed enzyme prodrug therapy Gedeptin as a potential immune-sensitizing platform that could enhance checkpoint inhibitor efficacy in solid tumors, aligning with rising industry investment in simplified in vivo cancer treatments.
Advanced Heart, Kidney and Metabolic Syndrome Linked to 30% Higher Cancer Risk, Study Finds
New research published in Circulation: Population Health and Outcomes reveals that later stages of cardiovascular-kidney-metabolic (CKM) syndrome are associated with a 25-30% increased risk of cancer, highlighting the need for integrated screening.
Powermax Minerals Identifies Rare Earth Targets at Atikokan Project, Strengthening North America's Critical Mineral Supply
Powermax Minerals refines exploration at its Atikokan Rare Earth Property in Ontario, identifying priority zones through integrated geochemical and geophysical data, supporting strategic demand for domestic REE supply.
LIXTE Biotechnology Advances Precision Cancer Treatment with Novel PP2A Inhibitor
LIXTE Biotechnology is pioneering a new approach in oncology with its lead compound LB-100, which enhances chemotherapy and radiation efficacy while reducing side effects, potentially improving patient outcomes.
SureNano Science Advances GLP-1 Drug Candidate Toward Clinical Trials, Expands Investor Outreach
SureNano Science Ltd. is moving its lead obesity and diabetes drug GEP-44 into FDA IND-enabling studies with LabCorp while broadening investor communications through a partnership with Investor Brand Network.
Lakeville Clinic Reports Early Neuropathy Improvement in Patient After Two Weeks
ALIGN Integrated Health in Lakeville, Minnesota reports that a Burnsville patient showed measurable improvement in neuropathy symptoms within two weeks of starting integrative treatment, highlighting the importance of early intervention.
Canamera Energy Metals Expands Brazil Auger Drill Program as Early Rare Earth Results Show Encouraging Grades
Canamera Energy Metals Corp. expanded its auger drilling program at the Turvolândia rare earth project in Brazil to 1,200 meters after early assays, including a hole returning 3,255 ppm TREO over 13 meters, indicated potential for ion adsorption clay-style mineralization.